No. MatMaCorp's COVID-19 Test Kit requires specimens to be collected by a healthcare provider.

• Limit of Detection (LoD) – The MatMaCorp COVID-19 test was determined to have a LoD of 800 genome equivalents per mL (40 genome equivalents per 50 ul reaction)
• Clinical Evaluation – The MatMaCorp COVID-19 test correctly detected 29 out of 30 clinical positive samples (96.7% concordance) and 30 out of 30 clinical negative samples (100% concordance), compared to the comparator method
• Inclusivity/reactivity – The MatMaCorp COVID-19 test is expected to detect at least 99.8% of sequences from known SARS-CoV-2 isolates, based on in silico analysis for inclusivity
• Specificity/cross-reactivity – The MatMaCorp COVID-19 test is not expected to cross-react with any normal or pathogenic respiratory flora likely to be encountered in a clinical specimen, based on in silico analysis for specificity

For more information, please visit Centers for Disease Control and Prevention